Brooktree Capital Management Cardlytics, Inc. Transaction History
Brooktree Capital Management
- $120 Million
- Q3 2024
A detailed history of Brooktree Capital Management transactions in Cardlytics, Inc. stock. As of the latest transaction made, Brooktree Capital Management holds 167,642 shares of CDLX stock, worth $632,010. This represents 0.45% of its overall portfolio holdings.
Number of Shares
167,642
Previous 134,473
24.67%
Holding current value
$632,010
Previous $1.1 Million
51.45%
% of portfolio
0.45%
Previous 0.95%
Shares
11 transactions
Others Institutions Holding CDLX
# of Institutions
130Shares Held
31MCall Options Held
1.23MPut Options Held
775K-
Cliff Sosin Cas Investment Partners, LLC | New York, Ny6.42MShares$24.2 Million1.36% of portfolio
-
Black Rock Inc. New York, NY3.15MShares$11.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.67MShares$10.1 Million0.0% of portfolio
-
683 Capital Management, LLC New York, NY2.23MShares$8.39 Million0.65% of portfolio
-
Kps Global Asset Management Uk LTD London, X01.22MShares$4.59 Million0.93% of portfolio
About Cardlytics, Inc.
- Ticker CDLX
- Exchange NASDAQ
- Sector Communication Services
- Industry Advertising Agencies
- Shares Outstandng 32,893,800
- Market Cap $124M
- Description
- Cardlytics, Inc. operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and var...